Literature DB >> 27028352

Synthesis, cytotoxic, anti-lipoxygenase and anti-acetylcholinesterase capacities of novel derivatives from harmine.

Insaf Filali1,2, Mohamed Amine Belkacem1,2, Aymen Ben Nejma1, Jean Pierre Souchard2, Hichem Ben Jannet1, Jalloul Bouajila2.   

Abstract

We synthesized two series of new hydrazide harmine derivatives. The reaction of harmine 1 with ethyl acetate chloride afforded the corresponding ethyl ester 2. The treatment of 2 with hydrazine hydrate gave the hydrazide 3 which further converted into hydrazones 4a-j and dihydrazides 5a-c. A series of new triazoles 7a-f has also been prepared from the suitable propargyl harmine 6. The synthesized derivatives were characterized by 1H-NMR, 13C-NMR, and HRMS and evaluated for their activities against MCF7, HCT116 OVCAR-3, acetylcholinesterase and 5-lipoxygenase. The most hydrazones derivatives 4a-j have a good cytotoxic activity against all cell lines, when 4a, 4d, 4f and 4 g are more active than 1 (against OVCAR-3 IC50 16.7-2.5 μM). The compound 6 was the most active (IC50 = 1.9 μM) against acetylcholinesterase. Some compounds exhibited significant activity against 5-lipoxygenase (IC50 = 30.9-63.1 μM).

Entities:  

Keywords:  5-lipoxygenase; Acetylcholinesterase; cytotoxic; hydrazide; triazoles

Mesh:

Substances:

Year:  2016        PMID: 27028352     DOI: 10.3109/14756366.2016.1163342

Source DB:  PubMed          Journal:  J Enzyme Inhib Med Chem        ISSN: 1475-6366            Impact factor:   5.051


  2 in total

1.  Synthesis and biological evaluation of novel N9-heterobivalent β-carbolines as angiogenesis inhibitors.

Authors:  Liang Guo; Qin Ma; Wei Chen; Wenxi Fan; Jie Zhang; Bin Dai
Journal:  J Enzyme Inhib Med Chem       Date:  2019-12       Impact factor: 5.051

2.  Synthesis and Biological Evaluation of Harmirins, Novel Harmine-Coumarin Hybrids as Potential Anticancer Agents.

Authors:  Kristina Pavić; Maja Beus; Goran Poje; Lidija Uzelac; Marijeta Kralj; Zrinka Rajić
Journal:  Molecules       Date:  2021-10-27       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.